| Tretinoin | Approved Investigational Nutraceutical | CYP2C9 | 1559 |
downregulated | Tretinoin results in decreased expression of CYP2C9 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2J2 | 1573 |
downregulated | Tretinoin results in decreased expression of CYP2J2 mRNA | 1p32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2S1 | 29785 |
upregulated | Tretinoin results in increased expression of CYP2S1 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2U1 | 113612 |
upregulated | Tretinoin results in increased expression of CYP2U1 mRNA | 4q25 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2W1 | 54905 |
downregulated | Tretinoin results in decreased expression of CYP2W1 mRNA | 7p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP39A1 | 51302 |
upregulated | Tretinoin results in increased expression of CYP39A1 mRNA | 6p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP3A4 | 1576 |
downregulated | Tretinoin results in decreased expression of CYP3A4 mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP3A4 | 1576 |
upregulated | [Tretinoin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP3A7 | 1551 |
downregulated | Tretinoin metabolite results in decreased expression of CYP3A7 mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP3A7 | 1551 |
downregulated | Tretinoin results in decreased expression of CYP3A7 mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP4A11 | 1579 |
downregulated | Tretinoin metabolite results in decreased expression of CYP4A11 mRNA | 1p33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP4A11 | 1579 |
downregulated | Tretinoin results in decreased expression of CYP4A11 mRNA | 1p33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP4B1 | 1580 |
downregulated | Tretinoin results in decreased expression of CYP4B1 mRNA | 1p33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP4B1 | 1580 |
upregulated | Tretinoin results in increased expression of CYP4B1 mRNA | 1p33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP4F11 | 57834 |
downregulated | Tretinoin results in decreased expression of CYP4F11 mRNA | 19p13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP4F3 | 4051 |
upregulated | Tretinoin results in increased expression of CYP4F3 mRNA | 19p13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP7A1 | 1581 |
downregulated | Tretinoin results in decreased expression of CYP7A1 mRNA | 8q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYR61 | 3491 |
upregulated | Tretinoin results in increased expression of CYR61 mRNA | 1p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CYTH1 | 9267 |
upregulated | Tretinoin results in increased expression of CYTH1 mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CYTL1 | 54360 |
downregulated | Tretinoin results in decreased expression of CYTL1 mRNA | 4p16.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DAAM1 | 23002 |
downregulated | Tretinoin results in decreased expression of DAAM1 mRNA | 14q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DAB1 | 1600 |
downregulated | Tretinoin results in decreased expression of DAB1 mRNA | 1p32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DAB2 | 1601 |
upregulated | Tretinoin results in increased expression of DAB2 mRNA | 5p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DACH1 | 1602 |
upregulated | Tretinoin results in increased expression of DACH1 mRNA | 13q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DACH2 | 117154 |
upregulated | Tretinoin results in increased expression of DACH2 mRNA | Xq21.2 | |